A carregar...
Adoptive Therapy with Chimeric Antigen Receptor Modified T Cells of Defined Subset Composition
The ability to engineer T cells to recognize tumor cells through genetic modification with a synthetic chimeric antigen receptor has ushered in a new era in cancer immunotherapy. The most advanced clinical applications are in in targeting CD19 on B cell malignancies. The clinical trials of CD19 CAR...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4149222/ https://ncbi.nlm.nih.gov/pubmed/24667960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000036 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|